Table 2.
Demographics of intent-to-treat (ITT) population
| Besifloxacin 0.6% N= 38 | Moxifloxacin 0.5% N = 38 | Gatifloxacin 0.3% N= 43 | Total N = 119 | |
|---|---|---|---|---|
| Age (years) | ||||
| Mean (SD) | 42.5 (14.3) | 40.5 (15.0) | 44.6 (17.0) | 42.6 (15.5) |
| Range | 20–66 | 18–68 | 18–74 | 18–74 |
| Gender | ||||
| Male | 17 (44.7%) | 12 (34.2%) | 16 (37.2%) | 46 (38.7%) |
| Female | 21 (55.3%) | 25 (65.8%) | 27 (62.8%) | 73 (61.3%) |
| Ethnicity | ||||
| Hispanic or Latino | 3 (7.9%) | 5 (13.2%) | 2 (4.7%) | 10 (8.4%) |
| Not Hispanic or Latino | 35 (92.1%) | 33 (86.8%) | 41 (95.3%) | 109 (91.6%) |
| Race | ||||
| American Indian/Alaskan Native | 1 (2.6%) | 0 (0.0%) | 0 (0.0%) | 1 (0.8%) |
| Asian | 0 (0.0%) | 1 (2.6%) | 1 (2.3%) | 2 (1.7%) |
| Black/African-American | 1 (2.6%) | 0 (0.0%) | 0 (0.0%) | 1 (0.8%) |
| White | 35 (92.1%) | 34 (89.5%) | 39 (90.7%) | 108 (90.8%) |
| Other | 1 (2.6%) | 3 (7.9%) | 3 (7.0%) | 7 (5.9%) |
| Iris color | ||||
| Blue | 10 (26.3%) | 7 (18.4%) | 10 (23.3%) | 27 (22.7%) |
| Brown | 15 (39.5%) | 19 (50.0%) | 21 (28.8%) | 55 (46.2%) |
| Green | 2 (5.3%) | 4 (10.5%) | 5 (11.6%) | 11 (9.2%) |
| Hazel | 11 (28.9%) | 8 (21.1%) | 7 (16.3%) | 26 (21.8%) |
Notes: Subject-reported races designated as ‘Other’ include: Native Indian/Latino (1), Spanish (1), Polish (1), Mulatto (1), Hispanic (1), and Puerto Rican (2).
Abbreviation: SD, standard deviation.